Selling half is not a bad strategy. Personally I think most of the blood letting is done and don't envisage too much more carnage.
The reason is that they have decided to appeal. To me this means Lilly still values Axiron which will underpin the stock at least until we get the result of the appeal. I am not a lawyer but the decision seems highly bizarre to me.
But its anyone's guess as to where the mini bounce will take us.
Strangely I am much more comfortable with the price at these levels then I was at 70c. It seemed to me that this crew "had it coming" to a large extent - and I believe this is the circuit breaker that I have been banging on about that the board needs as an excuse to implement some really tough changes. TOUGH CHANGES ARE REALLY NEEDED!. To me we are not getting anywhere as things are.
Just my ramblings......
Add to My Watchlist
What is My Watchlist?
